scholarly journals Long-Term Response to Daily Low-Dose Subcutaneous Interferon-α2b in a Patient with Pretreated Metastatic Uveal Melanoma in the Liver and Lung

2008 ◽  
Vol 1 (1) ◽  
pp. 5-10 ◽  
Author(s):  
Pia Vihinen ◽  
Seppo Pyrhönen
Keyword(s):  
Uveal Melanoma ◽  
Interferon Alpha ◽  
Low Dose ◽  
Interferon Alpha 2B ◽  
Term Response

Long-term Results of Intralesional Interferon Alpha-2B in Discoid Lupus Erythematosus

1993 ◽  
Vol 20 (7) ◽  
pp. 444-446 ◽  
Author(s):  
Jesús Martínez ◽  
Ricardo F. de Misa ◽  
Pablo Boixeda ◽  
José María Arrazola ◽  
Antonio Ledo
Keyword(s):  
Interferon Alpha ◽  
Lupus Erythematosus ◽  
Long Term Results ◽  
Discoid Lupus Erythematosus ◽  
Interferon Alpha 2B

Administration of low-dose epoetin-alpha facilitates adherence to ribavirin in triple therapy with pegylated interferon-alpha-2b and telaprevir

2014 ◽  
Vol 44 (10) ◽  
pp. E84-E91 ◽  
Author(s):  
Hisashi Ishida ◽  
Sadatsugu Sakane ◽  
Takashi Toyama ◽  
Keisuke Fukutomi ◽  
Keiichi Kimura ◽  
...  
Keyword(s):  
Triple Therapy ◽  
Interferon Alpha ◽  
Low Dose ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B ◽  
Epoetin Alpha

P14 Outcome of high risk melanoma patients treated with low dose interferon alpha 2B

1999 ◽  
Vol 9 (3) ◽  
pp. 328
Author(s):  
D. A. Vorobiof ◽  
D. E. Ostria ◽  
G. Vorobiof ◽  
M. R. Chasen
Keyword(s):  
High Risk ◽  
Interferon Alpha ◽  
Low Dose ◽  
Interferon Alpha 2B ◽  
High Risk Melanoma ◽  
Risk Melanoma ◽  
Melanoma Patients
Sign in / Sign up

Export Citation Format

Share Document